In addition, the combination of Q11 with other drugs targeting the tumor microenvironment needs further study, such as immunosuppressive drugs such as PD‐1/PD‐L1 antibodies and angiogenesis inhibitors such as bevacizumab, or chemotherapy drugs such as cyclophosphamide. Here, CD274 is linked to neoplasm.